National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

News & Events
 News Releases
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
  1998
  1997
  1996
  1995
  By Topic
 Qs & As
 Media Inquiries
 Events & Calendars
 NIAID Discovery News
 Focus on Features
 NIAID in the News
 Resources


National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov

FOR IMMEDIATE RELEASE
Tuesday, March 21, 2006
Media Contact: Anne A. Oplinger
(301) 402-1663
niaidnews@niaid.nih.gov

NIAID Updates “Focus on TB” Web Feature

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has updated “Focus on Tuberculosis (TB)” in advance of World TB Day, March 24. This Web feature describes TB research being done in NIAID’s labs in Bethesda, MD, and by NIAID-supported scientists across the country and around the world.

Every second of every day, someone is newly infected by Mycobacterium tuberculosis, the bacterium that causes TB. The ancient affliction still reigns as one of the world’s leading killers. Yet, there is reason for hope. Visit the Web site to read about research studies in progress such as these:

  • Improving a Tried and True Vaccine

    BCG for the 21st Century An NIAID grantee is using genetic engineering to improve BCG, a century-old TB vaccine. He is working on a better TB vaccine for infants; a “booster” shot for the four billion people worldwide who’ve previously received BCG vaccine; and a vaccine that will be safe for people with weakened immune systems.

  • U.S.-South Korean Collaboration Will Advance TB Care

    The National TB Hospital in Masan, South Korea, admits more than 500 patients a year with multidrug-resistant TB (MDR-TB). NIAID scientists have joined with researcher-clinicians at the hospital to improve imaging technology and other techniques that will speed diagnostics and new treatments for the often-fatal MDR-TB.

For these and other story ideas, visit the “Focus on TB” Web site at http://www3.niaid.nih.gov/news/focuson/tb/default.htm.


NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.

The National Institutes of Health (NIH) The Nation's Medical Research Agency includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

###

back to top


See Also

Media Contact Info

News Releases by Topic


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

Search in News & Events
 
Print Icon Print this page
E-mail Icon E-mail this page

See Also

Media Contact Info

News Releases by Topic